A group of international experts is proposing a first-of-its-kind framework to prevent multiple sclerosis (MS) from ...
The Epstein-Barr virus and a high-risk gene may work together to trick the immune system into attacking the brain in MS, a ...
The company recently hit significant roadblocks with its BTK inhibitor, but there are plenty of fish in the sea for the drug ...
Ongoing clinical trials are exploring therapies like tolebrutinib, fingolimod, and ocrelizumab, focusing on efficacy and safety in diverse patient populations. The MUSETTE trial confirmed that the ...
Scientists have uncovered a concerning link between something as common as table salt and one of medicine’s most puzzling autoimmune conditions. A groundbreaking study published in Science ...
NIH study reveals key players underlying disease onset and repair. Using an animal model of multiple sclerosis (MS), researchers at the National Institutes of Health (NIH) have created a ...
A Canadian-led international research team, spearheaded by Dr. Fang Liu at the Centre for Addiction and Mental Health (CAMH) has received nearly $800,000 US ($1,137,868 CAD) in new funding to advance ...
Oct. 01, 2025 7:50 AM ETQuantum BioPharma Ltd. (QNTM) “We are excited that Dr. Antel will be joining Quantum as a new clinical advisor. He brings a wealth of knowledge on MS that will be instrumental ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback